Literature DB >> 22325975

Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease).

Robert J Mentz1, Mona Fiuzat, Linda K Shaw, Harry R Phillips, Salvador Borges-Neto, G Michael Felker, Christopher M O'Connor.   

Abstract

Myocardial ischemic origin is a significant independent predictor of mortality in patients with heart failure (HF). The implications of angina pectoris (AP) in HF are less well characterized. The aim of this study was to compare the clinical characteristics and outcomes of patients with and without AP in a cohort of patients with reduced ejection fractions and ischemic cardiomyopathy (iCM). Patients who underwent coronary angiography at Duke University Medical Center from January 2000 to September 2009 with ejection fractions <40% and diagnoses of iCM with AP in the previous 6 weeks were compared to similar patients without AP. Time to event was examined using Kaplan-Meier methods for 5 end points: death; death or nonfatal myocardial infarction (MI); death, MI, or revascularization; death or hospitalization; and cardiovascular (CV) death or CV hospitalization. Of 2,376 patients with iCM, 1,412 (59%) had AP. They had more co-morbidities and more previous revascularization than patients without AP. After multivariate adjustment, those with and without AP had similar risks for death (p = 0.32), death or MI (p = 0.15), and death or hospitalization (p = 0.37) (5-year event rates 41% vs 41%, 46% vs 47%, and 87% vs 85%, respectively), but those with AP had lower rates of death, MI, or revascularization (p = 0.01) and higher rates of CV death or CV hospitalization (p = 0.03) (5-year event rates 85% vs 87% and 77% vs 73%, respectively). In conclusion, AP is common in patients with iCM despite medical therapy and previous revascularization and is associated with increased CV death or CV rehospitalization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22325975     DOI: 10.1016/j.amjcard.2011.12.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

Review 2.  Prediction of Post Percutaneous Coronary Intervention Myocardial Ischaemia.

Authors:  Alda Huqi; Giacinta Guarini; Doralisa Morrone; Mario Marzilli
Journal:  Eur Cardiol       Date:  2016-12

3.  Prehospital Delay in Older Adults with Acute Myocardial Infarction: The ComprehenSIVe Evaluation of Risk Factors in Older Patients with Acute Myocardial Infarction Study.

Authors:  Gregory M Ouellet; Mary Geda; Terrence E Murphy; Sui Tsang; Mary E Tinetti; Sarwat I Chaudhry
Journal:  J Am Geriatr Soc       Date:  2017-10-18       Impact factor: 5.562

4.  Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

Authors:  Tariq Ahmad; Michael J Pencina; Phillip J Schulte; Emily O'Brien; David J Whellan; Ileana L Piña; Dalane W Kitzman; Kerry L Lee; Christopher M O'Connor; G Michael Felker
Journal:  J Am Coll Cardiol       Date:  2014-10-21       Impact factor: 24.094

5.  Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction.

Authors:  Adam M Garber; Robert J Mentz; Hussein R Al-Khalidi; Linda K Shaw; Mona Fiuzat; Christopher M O'Connor; Eric J Velazquez
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

6.  Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION).

Authors:  Kishan S Parikh; Adrian Coles; Phillip J Schulte; William E Kraus; Jerome L Fleg; Steven J Keteyian; Ileana L Piña; Mona Fiuzat; David J Whellan; Christopher M O'Connor; Robert J Mentz
Journal:  Am J Cardiol       Date:  2016-07-29       Impact factor: 2.778

7.  Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).

Authors:  Robert J Mentz; Samuel Broderick; Linda K Shaw; Mona Fiuzat; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

8.  Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events.

Authors:  Robert J Mentz; Samuel Broderick; Linda K Shaw; Karen Chiswell; Mona Fiuzat; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2014-06-27       Impact factor: 15.534

9.  Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH.

Authors:  E Marc Jolicœur; Allison Dunning; Serenella Castelvecchio; Rafal Dabrowski; Myron A Waclawiw; Mark C Petrie; Ralph Stewart; Pardeep S Jhund; Patrice Desvigne-Nickens; Julio A Panza; Robert O Bonow; Benjamin Sun; Tan Ru San; Hussein R Al-Khalidi; Jean L Rouleau; Eric J Velazquez; John G F Cleland
Journal:  J Am Coll Cardiol       Date:  2015-11-10       Impact factor: 24.094

10.  Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study.

Authors:  Nicolas W Shammas; Gail A Shammas; Kathleen Keyes; Shawna Duske; Ryan Kelly; Michael Jerin
Journal:  Ther Clin Risk Manag       Date:  2015-03-23       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.